Paracetamol and phenacetin.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 3552585)

Published in Drugs on January 01, 1986

Authors

S P Clissold

Articles citing this

Key questions concerning paracetamol and NSAIDs for osteoarthritis. Ann Rheum Dis (2002) 1.64

Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br J Clin Pharmacol (1992) 1.24

PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial [ISCRTN 74418480]. BMC Cardiovasc Disord (2005) 1.22

Gastrointestinal tolerability of metamizol, acetaminophen, and diclofenac in subchronic treatment in rats. Dig Dis Sci (2002) 0.90

Pain management for dentists: the role of ibuprofen. Ann Stomatol (Roma) (2012) 0.85

Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studies. PLoS One (2013) 0.83

Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.82

PISA. The effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute stroke: protocol for a phase II double-blind randomised placebo-controlled trial [ISRCTN98608690]. BMC Cardiovasc Disord (2002) 0.81

Effects of naloxone and flumazenil on antinociceptive action of acetaminophen in rats. Curr Ther Res Clin Exp (2010) 0.81

The dose-related effects of paracetamol on hyperalgesia and nociception in the rat. Br J Pharmacol (1996) 0.80

Pharmacokinetics of common analgesics, anti-inflammatories and antipyretics in children. Clin Pharmacokinet (1989) 0.77

The Alzheimer pandemic: is paracetamol to blame? Inflamm Allergy Drug Targets (2014) 0.75

Pain management in pediatric day surgery patients at The Maternal and Child Medical Research Center in Mongolia. Korean J Anesthesiol (2010) 0.75

Articles cited by this

Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (1973) 4.40

Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther (1974) 2.62

Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol (1978) 2.18

Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chir Scand (1965) 1.92

Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol (1980) 1.87

Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol (1977) 1.76

Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs (1983) 1.70

Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology (1974) 1.70

Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet (1982) 1.54

A comparative evaluation of marketed analgesic drugs. N Engl J Med (1972) 1.50

Gastrointestinal absorption of drugs. Med Clin North Am (1974) 1.49

Adverse reactions of aspirin and related drugs. Arch Intern Med (1981) 1.39

Acetaminophen overdose in young children. Treatment and effects of alcohol and other additional ingestants in 417 cases. Am J Dis Child (1984) 1.25

Effects of aspirin and acetaminophen on the liver. Arch Intern Med (1981) 1.20

Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics. Drugs (1982) 1.14

Comparative analgesic efficacies of aspirin and acetaminophen. Arch Intern Med (1981) 1.13

Acetaminophen hepatotoxicity. Annu Rev Med (1984) 1.09

Fatal acetaminophen overdosage in a young child. J Pediatr (1978) 1.08

Teratogenic drugs--R.C.G.P. survey. Br Med J (1970) 1.07

Age as a variable in acetaminophen overdose. Arch Intern Med (1981) 1.07

The binding of paracetamol to plasma proteins of man and pig. J Pharm Pharmacol (1973) 1.06

The effects of particle size on the absorption of phenacetin in man. A correlation between plasma concentration of phenacetin and effects on the central nervous system. Clin Pharmacol Ther (1970) 1.05

Review of the comparative analgesic efficacy of salicylates, acetaminophen, and pyrazolones. Am J Med (1983) 1.03

Acetaminophen: a practical pharmacologic overview. Can Med Assoc J (1984) 0.97

New peripherally-acting oral analgesic agents. Annu Rev Pharmacol Toxicol (1983) 0.96

Acetaminophen poisoning in infancy. Am J Dis Child (1983) 0.94

Renal clearance and serum protein binding of acetaminophen and its major conjugates in humans. J Pharm Sci (1984) 0.93

Long-term ingestion of paracetamol and liver disease. J R Soc Med (1980) 0.93

Drug interactions affecting analgesic toxicity. Am J Med (1983) 0.92

Diflunisal. A new oral analgesic with an unusually long duration of action. JAMA (1982) 0.91

The comparative metabolism of phenacetin and N-acetyl-p-aminophenol in man, with particular reference to effects on the kidney. Clin Pharmacol Ther (1968) 0.89

A comparison of acetophenetidin and acetaminophen. II. Subjective effects in healthy volunteers. J Pharmacol Exp Ther (1967) 0.89

Paracetamol. Postgrad Med J (1980) 0.88

The fate of acetophenetidin in man and methods for the estimation of acetophenetidin and its metabolites in biological material. J Pharmacol Exp Ther (1949) 0.88

Acetaminophen overdose. Am J Med (1983) 0.84

Biologic importance of arachidonic acid. Arch Intern Med (1981) 0.84

Gastrointestinal effects of antipyretic analgesics. Am J Med (1983) 0.83

Effects of aspirin and acetaminophen in gastrointestinal hemorrhage. Results from the Boston Collaborative Drug Surveillance Program. Arch Intern Med (1981) 0.82

Phenacetin and paracetamol. J Int Med Res (1976) 0.81

Reactive metabolites of phenacetin and acetaminophen: a review. Environ Health Perspect (1983) 0.81

Cold comfort for hot children. Br Med J (Clin Res Ed) (1983) 0.80

Acetaminophen: report of an unusual poisoning. Pediatrics (1978) 0.79

Therapeutic implications of drug interactions with acetaminophen and aspirin. Arch Intern Med (1981) 0.77

A controlled evaluation of orally administered aspirin, dipyrone and placebo in patients with post-operative pain. Curr Med Res Opin (1980) 0.76

Analgesic nephropathy. Br Med J (Clin Res Ed) (1981) 0.76

A comparison of acetophenetidin and acetaminophen. I. Analgesic effects in postpartum patients. J Pharmacol Exp Ther (1967) 0.76

Analgesic nephropathy associated with paracetamol. Aust N Z J Med (1984) 0.75

Drug-induced renal disease. Practitioner (1978) 0.75

Articles by these authors

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs (1987) 2.54

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs (1990) 2.52

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs (1989) 2.41

Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs (1985) 2.21

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs (1991) 1.96

Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states. Drugs (1990) 1.61

Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs (1987) 1.43

Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs (1986) 1.34

Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs (1992) 1.28

Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs (1991) 1.18

Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs (1991) 1.17

Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1985) 1.13

Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion. Drugs (1989) 1.08

Bifonazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses. Drugs (1989) 1.08

Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Drugs (1992) 1.08

Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica. Drugs (1987) 1.01

Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs (1986) 1.00

Salbutamol in the 1980s. A reappraisal of its clinical efficacy. Drugs (1989) 0.98

Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis. Drugs (1984) 0.95

Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders. Drugs (1987) 0.94

Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases. Drugs (1991) 0.91

Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders. Drugs (1986) 0.90

Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease. Drugs (1987) 0.86

Brotizolam. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an hypnotic. Drugs (1988) 0.84

Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease. Drugs (1992) 0.83

Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases. Drugs (1987) 0.83

Bendazac lysine. A review of its pharmacological properties and therapeutic potential in the management of cataracts. Drugs (1990) 0.81

Flutamide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer. Drugs (1989) 0.80

Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs (1985) 0.80

Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses. Drugs (1986) 0.79

Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension. Drugs (1990) 0.79

Aspirin and related derivatives of salicylic acid. Drugs (1986) 0.77

Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs (1992) 0.77

Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease. Drugs (1990) 0.76

Proquazone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases and pain states. Drugs (1987) 0.75

Doxacurium. A review of its pharmacology and clinical potential in anaesthesia. Drugs (1991) 0.75

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study. Int J Clin Pract (2010) 0.75

Cadralazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. Drugs (1990) 0.75

Sulconazole. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses. Drugs (1988) 0.75

Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction. Drugs (1990) 0.75

Ocular levobunolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs (1987) 0.75

Proceedings: Some pharmacological studies on uraemia. J Pharm Pharmacol (1975) 0.75